PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+7.79%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$129M
AUM Growth
+$129M
(+7.9%)
Cap. Flow
+$2.48M
Cap. Flow
% of AUM
1.93%
Top 10 Holdings %
Top 10 Hldgs %
47.97%
Holding
87
New
18
Increased
15
Reduced
10
Closed
17
Top Buys
| 1 |
Baxter International
BAX
|
$9.93M |
| 2 |
Cigna
CI
|
$5.05M |
| 3 |
Humana
HUM
|
$4.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$4.75M |
| 5 |
CONMED
CNMD
|
$4.72M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$9.79M |
| 2 |
ResMed
RMD
|
$8.01M |
| 3 |
Edwards Lifesciences
EW
|
$4.99M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$4.52M |
| 5 |
Exact Sciences
EXAS
|
$4.41M |
Sector Composition
| 1 | Healthcare | 82.73% |
| 2 | Financials | 0% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$12.7B
| $9.93M | 5.13% | +145,000 | New | +$9.93M |
|
2
Boston Scientific
BSX
$156B
| $9.32M | 4.81% | 525,000 -75,000 | -13% | -$1.33M |
|
3
Insulet
PODD
$23.9B
| $5.7M | 2.94% | 170,900 +135,400 | +381% | +$4.52M |
|
|
4
Edwards Lifesciences
EW
$47.8B
| $5.7M | 2.94% | 40,000 -35,000 | -47% | -$4.99M |
|
|
5
Jazz Pharmaceuticals
JAZZ
$7.75B
| $5.62M | 2.9% | 32,500 +27,500 | +550% | +$4.75M |
|
|
ALIM
6
DELISTED
Alimera Sciences, Inc.
ALIM
| $5.59M | 2.88% | 1,115,991 +163,087 | +17% | +$817K |
|
|
SIEN
7
DELISTED
Sientra, Inc.
SIEN
| $5.24M | 2.7% | 273,100 +121,977 | +81% | +$2.34M |
|
|
8
Cigna
CI
$80.3B
| $5.05M | 2.6% | +39,000 | New | +$5.05M |
|
|
9
Humana
HUM
$36.5B
| $4.9M | 2.53% | +27,500 | New | +$4.9M |
|
|
10
CONMED
CNMD
$1.68B
| $4.72M | 2.43% | +93,405 | New | +$4.72M |
|
11
Bausch Health
BHC
$2.74B
| $4.37M | 2.25% | 22,000 -1,875 | -8% | -$372K |
|
12
Teleflex
TFX
$5.59B
| $4.23M | 2.18% | +35,000 | New | +$4.23M |
|
13
Smith & Nephew
SNN
$16.3B
| $4.19M | 2.16% | 122,500 +22,500 | +23% | +$769K |
|
|
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
| $3.67M | 1.89% | 79,800 +17,950 | +29% | +$826K |
|
|
RCPT
15
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.55M | 1.83% | 21,500 -1,000 | -4% | -$165K |
|
|
AGN
16
DELISTED
Allergan plc
AGN
| $3.24M | 1.67% | 10,875 +7,450 | +218% | +$2.22M |
|
|
HRC
17
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.94M | 1.52% | 60,000 +10,000 | +20% | +$490K |
|
18
Cooper Companies
COO
$13.4B
| $2.81M | 1.45% | +15,000 | New | +$2.81M |
|
|
AKRX
19
DELISTED
Akorn, Inc.
AKRX
| $2.8M | 1.45% | +59,000 | New | +$2.8M |
|
|
NVCN
20
DELISTED
Neovasc Inc.
NVCN
| $2.79M | 1.44% | 309,982 -4,298 | -1% | -$38.7K |
|
|
TRNX
21
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.4M | 1.24% | 91,600 -7,400 | -7% | -$194K |
|
22
Tandem Diabetes Care
TNDM
$845M
| $2.37M | 1.22% | +187,738 | New | +$2.37M |
|
23
AngioDynamics
ANGO
$417M
| $2.22M | 1.15% | +125,000 | New | +$2.22M |
|
24
Teva Pharmaceuticals
TEVA
$21.1B
| $2.1M | 1.08% | 33,650 +2,150 | +7% | +$134K |
|
|
CYBX
25
DELISTED
CYBERONICS INC
CYBX
| $1.95M | 1.01% | 30,000 -66,200 | -69% | -$4.3M |
|